Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Bellicum Pharma, OvaScience, Comstock

Thu, 18th Dec 2014 16:13

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stocks rose on Thursday, with each of the major indexesclimbing more than 1 percent, building on the prior session'srally after the U.S. Federal Reserve's policy statement and oilprices that showed signs of steadying. The Dow Jones industrialaverage rose 0.75 percent, the S&P 500 were up 0.8percent and the Nasdaq Composite were up 1.36 percent.

** BELLICUM PHARMACEUTICALS INC, $26.08, +37.26 pct

The biopharmaceutical company's shares rose as much as 40percent on its debut on Thursday. The company offerd 7.35million shares at $19, above $15-$17 marketed range.

** SILICON IMAGE INC, $4.9501, -26.56 pct

The chipmaker said it expects revenue to fall 10 percent in2015 due to fewer mobile design wins from one its largestcustomers.

** OVASCIENCE INC, $45.93, +31.38 pct

Wedbush Securities raised its rating on the fertilitytreatment developer to "outperform" from "neutral" after companysaid it will launch 2 fertility products and gave update on theprogress of third treatment.

** COMSTOCK RESOURCES INC, $6.02, -12.12 pct

The oil and gas producer said it plans to suspend oildrilling in Eagle Ford shale properties in south and east Texasand Tuscaloosa Marine shale in Mississippi as oil prices plunge.

** TETRAPHASE PHARMACEUTICALS INC, $38.0601, +14.67pct

The drug developer said its antibiotic to treat complicatedintra-abdominal infections was as effective as Merck & Co Inc's ertapenem in a late-stage study.

** DUNKIN' BRANDS GROUP INC, $42.35, -8.37 pct

The Dunkin' Donuts restaurant operator cut its 2015 forecastfor same-store sales growth in the United States and operatingincome growth, citing slowing sales of packaged coffee in itsrestaurants.

** AGENUS INC, $3.664, +9.37 pct

** GLAXOSMITHKLINE PLC, $42.979, +2.23 pct

The biotechnology company said an experimental vaccineagainst shingles by its partner GlaxoSmithKline met itsgoal in a late-stage study. Agenus will get royalties onpotential commercial sales of the vacine.

** ORACLE INC, $44.26, +7.53 pct

The software maker reported a 3.5 percent increase inquarterly revenue on Wednesday, beating Wall Street'sexpectations, as sales at its closely watched cloud servicesbusiness rose 45 percent.

** WINNEBAGO INDUSTRIES INC, $21.695, -9.04 pct

The maker of motorhomes and camping trailers reported alower-than-expected profit as a shortage of workers at a keyplant in rural Iowa and trouble sourcing key components fromsuppliers stymied production of the company's recreationalvehicles.

** REAL GOODS SOLAR INC, $0.6507, +12.19 pct

The solar company said it won more than 80 contracts toinstall rooftop solar power systems on homes and smallbusinesses. The company said the projects represent more than600kW of solar power.

** ACCENTURE PLC, $89.25, +4.63 pct

The consulting and outsourcing company raised its revenueforecast for fiscal 2015 after contract wins helped the companypost better-than-expected first-quarter earnings and revenue. The company said it expects revenue growth of 5-8 percent forthe year ending August on a local currency basis, up from the4-7 percent growth it had estimated earlier.

** RITE AID CORP, $6.77, +11.72 pct

The U.S. drugstore chain raised its full-year earningsforecast after cutting it twice this year as higher sales ofprescription drugs pushed up its profit and revenue in the thirdquarter.

** AK STEEL HOLDING CORP, $5.91, +6.30 pct

The steel maker said it expects fourth-quarter shipments tojump 37 percent compared with the third quarter, helped byacquisitions and strong demand from auto industry.

** THE PANTRY INC, $36.555, +2.91 pct

Canadian convenience store operator Alimentation Couche-TardInc will buy the Kangaroo Express chain operator forabout $861 million to boost its presence in the southeastern andGulf Coast regions. Couche-Tard offered $36.75 per share forPantry, which represents a premium of 3.5 percent to the stock'sWednesday close. Including debt, the deal is valued at $1.7billion. Pantry stock jumped 23 percent on Wednesday after theWall Street Journal reported that the company was nearing a dealto sell itself through an auction.

** BLACKBERRY LTD, $10.14, +1.60 pct

The Canadian mobile technology company launched itslong-awaited Classic on Wednesday, a smartphone it hopes willhelp it win back market share and woo those still using olderversions of its physical keyboard devices.

** ZAGG INC, $6.2, +16.32 pct

The mobile accessories maker raised its full-year net salesforecast to $250 million-$255 million from previous range of$225 million-$235 million. The forecast also beat analysts'average estimate of $232.5 million, according to Thomson ReutersI/B/E/S.

** EXXON MOBIL CORP, $88.57, -0.51 pct

** CHEVRON CORP, $105.89, -0.12 pct

** CONOCOPHILLIPS, $67.09, +0.22 pct

** CHESAPEAKE ENERGY CORP, $18.83, +0.80 pct

Oil company stocks rise after Brent crude jumps 3.3percent to above $63/bbl, extending a rebound from 5-year lowsthis week as more energy firms cut investment in new production.

** HERTZ GLOBAL HOLDINGS INC, $22.64, +6.24 pct

Carl Icahn, the rental car company's largest shareholder,raised stake in the company to 11.34 percent from 10.77 percent.Icahn revealed an 8.48 percent stake in Hertz in August; he hassince ousted CEO Mark Frissora and won three board seats at thecompany.

** KIRBY CORP, $82.325, -7.24 pct

The tank bank operator lowered fourth quarter earningsestimate to $1.10-$1.20 per share from $1.30-$1.40 per share.The company also lowered its full year earnings estimate to$4.84 to $4.94 per share from $5.04-$5.14 per share.

** GENWORTH FINANCIAL INC, $7.89, -0.50 pct

The life and mortgage insurer said the review of long termcare insurance active life margins is taking longer thanexpected. The company said it now expects to complete review onor before fourth quarter results in February.

** JABIL CIRCUIT INC, $20.65, +2.89 pct

The company, which makes phone casings for Apple Inc, forecasts second-quarter revenue above estimates,boosted by strong sales of iPhone 6 and 6 Plus. The companyforecast second quarter core earnings of 39-50 cents per share,higher than analysts' average estimate of profit of 38 cents pershare.

** NATIONAL BANK OF GREECE, $1.94, -2.51 pct

The largest Greek bank's U.S.-listed shares down afterfirst-round presidential vote in Greece saw Prime MinisterAntonis Samaras lose by larger-than-expected margin. (Compiled by Anannya Pramanick in Bangalore; Edited by DonSebastian)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.